Literature DB >> 30649187

Trends in Oral Antibiotic Prescription in Dermatology, 2008 to 2016.

John S Barbieri1, Ketaki Bhate1, Kathleen P Hartnett2,3,4, Katherine E Fleming-Dutra2, David J Margolis1,5.   

Abstract

Importance: Dermatologists prescribe more oral antibiotic courses per clinician than any other specialty, and this use puts patients at risk of antibiotic-resistant infections and antibiotic-associated adverse events. Objective: To characterize the temporal trends in the diagnoses most commonly associated with oral antibiotic prescription by dermatologists, as well as the duration of this use. Design, Setting, and Participants: Repeated cross-sectional analysis of antibiotic prescribing by dermatologists from January 1, 2008, to December 31, 2016. The setting was Optum Clinformatics Data Mart (Eden Prairie, Minnesota) deidentified commercial claims data. Participants were dermatology clinicians identified by their National Uniform Claim Committee taxonomy codes, and courses of oral antibiotics prescribed by these clinicians were identified by their National Drug Codes. Exposures: Claims for oral antibiotic prescriptions were consolidated into courses of therapy and associated with the primary diagnosis from the most recent visit. Courses were stratified into those of extended duration (>28 days) and those of short duration (≤28 days). Main Outcomes and Measures: Frequency of antibiotic prescribing and associated diagnoses. Poisson regression models were used to assess for changes in the frequency of antibiotic prescribing over time.
Results: Between 2008 and 2016 among 985 866 courses of oral antibiotics prescribed by 11 986 unique dermatologists, overall antibiotic prescribing among dermatologists decreased 36.6% (1.23 courses per 100 visits) from 3.36 (95% CI, 3.34-3.38) to 2.13 (95% CI, 2.12-2.14) courses per 100 visits with a dermatologist (prevalence rate ratio for annual change, 0.931; 95% CI, 0.930-0.932), with much of this decrease occurring among extended courses for acne and rosacea. Oral antibiotic use associated with surgical visits increased 69.6% (2.73 courses per 100 visits) from 3.92 (95% CI, 3.83-4.01) to 6.65 (95% CI, 6.57-6.74) courses per 100 visits associated with a surgical visit (prevalence rate ratio, 1.061; 95% CI, 1.059-1.063). Conclusions and Relevance: Continuing to develop alternatives to oral antibiotics for noninfectious conditions, such as acne, can improve antibiotic stewardship and decrease complications from antibiotic use. In addition, the rising use of postoperative antibiotics after surgical visits is concerning and may put patients at unnecessary risk of adverse events. Future studies are needed to identify the value of this practice and the risk of adverse events.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30649187      PMCID: PMC6439939          DOI: 10.1001/jamadermatol.2018.4944

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  58 in total

1.  Colonisation rates of Streptococcus pyogenes and Staphylococcus aureus in the oropharynx of a young adult population.

Authors:  R M Levy; J J Leyden; D J Margolis
Journal:  Clin Microbiol Infect       Date:  2005-02       Impact factor: 8.067

2.  Prospective study of wound infections in dermatologic surgery in the absence of prophylactic antibiotics.

Authors:  Anthony J Dixon; Mary P Dixon; Deborah A Askew; David Wilkinson
Journal:  Dermatol Surg       Date:  2006-06       Impact factor: 3.398

3.  Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008.

Authors:  Tina I Wright; Larry M Baddour; Elie F Berbari; Randall K Roenigk; P Kim Phillips; M Amanda Jacobs; Clark C Otley
Journal:  J Am Acad Dermatol       Date:  2008-09       Impact factor: 11.527

4.  The Role of the Physician in Patient Perceptions of Barriers to Primary Adherence With Acne Medications.

Authors:  Kira L Ryskina; Erica Goldberg; Briana Lott; Davis Hermann; John S Barbieri; Jules B Lipoff
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

5.  Effect of antibiotics on the oropharyngeal flora in patients with acne.

Authors:  Ross M Levy; Eric Y Huang; Daniel Roling; James J Leyden; David J Margolis
Journal:  Arch Dermatol       Date:  2003-04

6.  Prevention of Orthopaedic Implant Infection in Patients Undergoing Dental Procedures.

Authors:  William Watters; Michael P Rethman; Nicholas Buck Hanson; Elliot Abt; Paul A Anderson; Karen C Carroll; Harry C Futrell; Kevin Garvin; Stephen O Glenn; John Hellstein; Angela Hewlett; David Kolessar; Calin Moucha; Richard J O'Donnell; John E O'Toole; Douglas R Osmon; Richard Parker Evans; Anthony Rinella; Mark J Steinberg; Michael Goldberg; Helen Ristic; Kevin Boyer; Patrick Sluka; William Robert Martin; Deborah S Cummins; Sharon Song; Anne Woznica; Leeaht Gross
Journal:  J Am Acad Orthop Surg       Date:  2013-03       Impact factor: 3.020

7.  Adherence to topical therapy increases around the time of office visits.

Authors:  Steven R Feldman; Fabian T Camacho; Jennifer Krejci-Manwaring; Christie L Carroll; Rajesh Balkrishnan
Journal:  J Am Acad Dermatol       Date:  2007-05-10       Impact factor: 11.527

8.  Emergency department visits for antibiotic-associated adverse events.

Authors:  Nadine Shehab; Priti R Patel; Arjun Srinivasan; Daniel S Budnitz
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

9.  Duration of oral antibiotic therapy for the treatment of adult acne: a retrospective analysis investigating adherence to guideline recommendations and opportunities for cost-savings.

Authors:  Chelsey E Straight; Young H Lee; Guodong Liu; Joslyn S Kirby
Journal:  J Am Acad Dermatol       Date:  2015-03-07       Impact factor: 11.527

10.  Preliminary report of associated factors in wound infection after major head and neck neoplasm operations--does the duration of prophylactic antibiotic matter?

Authors:  S-A Liu; K-C Tung; J-Y Shiao; Y-T Chiu
Journal:  J Laryngol Otol       Date:  2007-04-20       Impact factor: 1.469

View more
  14 in total

Review 1.  Oral Antibiotics for Acne.

Authors:  Dillon J Patel; Neal Bhatia
Journal:  Am J Clin Dermatol       Date:  2021-03       Impact factor: 7.403

2.  Use of Antibiotics for Dermatologic Procedures From 2008 to 2016.

Authors:  John S Barbieri; Jeremy R Etzkorn; David J Margolis
Journal:  JAMA Dermatol       Date:  2019-04-01       Impact factor: 10.282

3.  Real-world drug usage survival of spironolactone versus oral antibiotics for the management of female patients with acne.

Authors:  John S Barbieri; Juliana K Choi; William D James; David J Margolis
Journal:  J Am Acad Dermatol       Date:  2019-03-21       Impact factor: 11.527

4.  Sarecycline Demonstrates Clinical Effectiveness against Staphylococcal Infections and Inflammatory Dermatoses: Evidence for Improving Antibiotic Stewardship in Dermatology.

Authors:  Ayman Grada; Mahmoud A Ghannoum; Christopher G Bunick
Journal:  Antibiotics (Basel)       Date:  2022-05-27

5.  Antimicrobial-induced oral dysbiosis exacerbates naturally occurring alveolar bone loss.

Authors:  Brooks A Swanson; Matthew D Carson; Jessica D Hathaway-Schrader; Amy J Warner; Joy E Kirkpatrick; Alexa Corker; Alexander V Alekseyenko; Caroline Westwater; J Ignacio Aguirre; Chad M Novince
Journal:  FASEB J       Date:  2021-11       Impact factor: 5.191

6.  Trends in Mail-Order Pharmacy Use in the U.S. From 1996 to 2018: An Analysis of the Medical Expenditure Panel Survey.

Authors:  Duy Do; Pascal Geldsetzer
Journal:  Am J Prev Med       Date:  2021-05-03       Impact factor: 6.604

7.  Sarecycline treatment for acne vulgaris: Rationale for weight-based dosing and limited impact of food intake on clinical efficacy.

Authors:  Ayman Grada; James Q Del Rosso; Emmy Graber; Christopher G Bunick; Linda Stein Gold; Angela Y Moore; Hilary Baldwin; Zaidal Obagi; Giovanni Damiani; Timothy Carrothers; Brian McNamee; Eva Hanze
Journal:  Dermatol Ther       Date:  2021-12-30       Impact factor: 3.858

8.  Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience.

Authors:  Vincenzo Bettoli; Aurora Guerra-Tapia; Maria Isabel Herane; Jaime Piquero-Martín
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-12-30

Review 9.  Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and Inflammation.

Authors:  Christopher G Bunick; Jonette Keri; S Ken Tanaka; Nika Furey; Giovanni Damiani; Jodi L Johnson; Ayman Grada
Journal:  Antibiotics (Basel)       Date:  2021-04-15

10.  Intraosseous epidermal cyst of the great toe that was difficult to distinguish from chronic osteomyelitis: A case report and literature review.

Authors:  Hikaru Sugimoto; Kensuke Yasue; Misako Hara; Shoichiro Takakuma; Wako Yumura; Tomio Arai; Kentaro Hayakawa; Fumiaki Tokimura; Tsuyoshi Miyazaki
Journal:  Clin Case Rep       Date:  2021-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.